Eric Low
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 14
- Multiple Myeloma Research and Treatments 14
- Oncology 10
- Cancer Treatment and Pharmacology 7
- Bone health and treatments 2
- Co-authors
- Jenny Bird (3 shared papers)Richard Soutar (3 shared papers)Helen Lucraft (2 shared papers)A. T. Reece (2 shared papers)Diana Samson (2 shared papers)Graham Jackson (2 shared papers)Shirley D’Sa (3 shared papers)Guy Pratt (7 shared papers)
- Journals
- British Journal of Haematology (6 papers)Value in Health (4 papers)Blood (3 papers)International Journal of Technology Assessment in Health Care (2 papers)The Lancet Haematology (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Eric Low
22 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 80
- Hematology 816
- Genetics 147
- Oncology 339
- Neurology 87
- Molecular Biology 328
Countries citing papers authored by Eric Low
This map shows the geographic impact of Eric Low's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Low with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Low more than expected).
Fields of papers citing papers by Eric Low
This network shows the impact of papers produced by Eric Low. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Low. The network helps show where Eric Low may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Low, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 288 | |
| 2 | 2011 | 222 | |
| 3 | 2011 | 154 | |
| 4 | 2004 | 140 | |
| 5 | 2009 | 87 | |
| 6 | 2017 | 46 | |
| 7 | 2017 | 44 | |
| 8 | 2017 | 42 | |
| 9 | 2023 | 37 | |
| 10 | 2016 | 34 | |
| 11 | 2020 | 15 | |
| 12 | 2016 | 9 | |
| 13 | 2015 | 5 | |
| 14 | 2020 | 5 | |
| 15 | 2015 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2016 | 4 | |
| 18 | 2007 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2020 | 2 |
About Eric Low
Eric Low is a scholar working on Hematology, Oncology, Molecular Biology, Economics and Econometrics and Genetics, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (14 papers), Cancer Treatment and Pharmacology (7 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Protein Degradation and Inhibitors (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Biomedical Ethics and Regulation (2 papers), Bone health and treatments (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (816 citations), Genetics (147 citations), Oncology (339 citations), Neurology (87 citations) and Molecular Biology (328 citations). Eric Low has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Jenny Bird, Richard Soutar, Helen Lucraft, A. T. Reece, Diana Samson, Graham Jackson, Shirley D’Sa, Guy Pratt, John A. Snowden and Jennifer M. Bird. Their work appears in journals such as British Journal of Haematology, Value in Health, Blood, International Journal of Technology Assessment in Health Care and The Lancet Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.